Rheumatology research

The Rheumatology Research team at Harrogate Hospital consists of Doctors, Research Nurses, Clinical Trials Assistants, Pharmacy, Labs and the  Research and Development Department. We provide the opportunity for our patients to participate in new trials for all different types of Rheumatology conditions.

The team:

Investigators

Dr Andrew Gough

Dr Mike Green

Dr Cathy Lawson

Dr Helen MacIver

Research Team

Esther Gordon , Research Nurse: Esther.Gordon@hdft.nhs.uk

Nadira Singh, Research Nurse: Nadira.Singh@hdft.nhs.uk

Alison Miernik, Clinical Trials Assistant: Alison.Miernik@hdft.nhs.uk

Debbie Elliott, Clinical Trials Assistant: Debbie.Elliott@hdft.nhs.uk  

How to contact us:

Address:       

Research Office

Farndale Suite

Harrogate District Hospital

Lancaster Park Road

Harrogate

North Yorkshire

HG2 7SX

Direct Telephone:    01423 555617

Welcome to the Rheumatology Research page.

The Rheumatology Research team at Harrogate Hospital consists of Doctors, Research Nurses, Clinical Trials Assistants, Pharmacy, Labs and the  Research and Development Department.

They provide the opportunity for patients to participate in new trials for all different types of Rheumatology conditions.

Please contact the team on the details above if you need any further information.

Rheumatology Research Trials:

RECRUITING NOW

RAMS

A study for Rheumatoid Arthritis patients newly starting Methotrexate.

The purpose of the study is to see whether we can predict who will do well and who will have to stop taking using methotrexate.

 

 

GCA

A study for patients with Giant Cell Arteritis and Polymyalgia Rheumatica.

Retrospective study looking at causes of GCA and PMR and how to predict whether a person with these condition will be more severely affected or only mildly affected.

 

ILD

For patients with Interstitial lung disease and connective tissue disease.

To identify and characterise disease susceptibility genes and autoantibodies associated with the development and clinical characteristics of ILD in patients with and without CTDs.

Prevent RA

This is a study for relatives of patients with Rheumatoid Arthritis looking at genetic, environmental and other factors to understand what makes people more/less likely to develop rheumatoid arthritis.

BRAGGSS/BSRBR

A study conducted by Manchester University for Rheumatoid Arthritis patients starting Biologics treatment.

CONVAS

An observational study for patients with Connective Tissue Disease

The Leeds Teaching Hospitals NHS Trusts aims to develop a comprehensive research program to investigate the clinical characteristics of patients attending the clinic.  This would be of great benefit in providing further insights into the differing diseases in order to assist with future treatments.

 

COMPLETED STUDY AND AWAITING RESULTS

PROMOTE

This is a trial conducted by the University of York for people with Osteoarthritis of the Knee.

The study was a 52 week trial and patients were randomised to either methotrexate or Placebo.